Corcept Therapeutics Incorporated
Utility Patents
Last updated:
List of all Corcept Therapeutics Incorporated patents 5 in total
| Status | Patent |
|---|---|
Grant | Utility: Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4 Filling date: 6 Sep 2025 Issue date: 29 Mar 2022 |
Grant | Utility: Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent Filling date: 6 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Methods for shrinking pituitary tumors Filling date: 6 Sep 2025 Issue date: 16 Mar 2021 |
Showing 1 to 5 of 5 patents.